Manchester Capital Management LLC Maintains Holdings in Danaher Corporation (DHR)

Manchester Capital Management LLC maintained its stake in shares of Danaher Corporation (NYSE:DHR) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,887 shares of the conglomerate’s stock at the end of the 2nd quarter. Manchester Capital Management LLC’s holdings in Danaher Corporation were worth $244,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently modified their holdings of DHR. Waldron LP purchased a new position in shares of Danaher Corporation during the first quarter valued at approximately $320,000. Empire Life Investments Inc. boosted its position in shares of Danaher Corporation by 2.3% during the first quarter. Empire Life Investments Inc. now owns 77,900 shares of the conglomerate’s stock valued at $6,662,000 after buying an additional 1,764 shares during the period. Trust Co. of Vermont boosted its position in shares of Danaher Corporation by 4.8% during the first quarter. Trust Co. of Vermont now owns 30,262 shares of the conglomerate’s stock valued at $2,588,000 after buying an additional 1,386 shares during the period. Xact Kapitalforvaltning AB boosted its position in shares of Danaher Corporation by 50.1% during the first quarter. Xact Kapitalforvaltning AB now owns 100,549 shares of the conglomerate’s stock valued at $8,600,000 after buying an additional 33,566 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its position in shares of Danaher Corporation by 4.2% during the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 355,219 shares of the conglomerate’s stock valued at $30,382,000 after buying an additional 14,462 shares during the period. 75.69% of the stock is currently owned by institutional investors.

In related news, insider William King sold 43,688 shares of Danaher Corporation stock in a transaction that occurred on Thursday, August 31st. The shares were sold at an average price of $82.86, for a total value of $3,619,987.68. Following the completion of the sale, the insider now owns 45,748 shares in the company, valued at approximately $3,790,679.28. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Linda P. Hefner sold 10,578 shares of Danaher Corporation stock in a transaction that occurred on Friday, July 21st. The shares were sold at an average price of $83.03, for a total transaction of $878,291.34. Following the completion of the sale, the director now owns 42,151 shares of the company’s stock, valued at approximately $3,499,797.53. The disclosure for this sale can be found here. Insiders sold a total of 71,496 shares of company stock valued at $5,916,223 in the last quarter. 12.20% of the stock is owned by insiders.

Several brokerages have issued reports on DHR. Wells Fargo & Company restated a “market perform” rating on shares of Danaher Corporation in a research report on Saturday, July 22nd. Cowen and Company restated a “buy” rating and set a $90.00 target price on shares of Danaher Corporation in a research report on Wednesday, October 4th. Jefferies Group LLC restated a “buy” rating and set a $95.00 target price on shares of Danaher Corporation in a research report on Friday, August 4th. BidaskClub lowered Danaher Corporation from a “hold” rating to a “sell” rating in a research report on Tuesday, July 25th. Finally, Morgan Stanley restated an “overweight” rating and set a $95.00 target price (up previously from $86.00) on shares of Danaher Corporation in a research report on Friday, October 6th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, twelve have assigned a buy rating and one has given a strong buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of $92.62.

TRADEMARK VIOLATION WARNING: “Manchester Capital Management LLC Maintains Holdings in Danaher Corporation (DHR)” was reported by Markets Daily and is the sole property of of Markets Daily. If you are viewing this article on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark law. The legal version of this article can be read at https://www.themarketsdaily.com/2017/10/11/manchester-capital-management-llc-maintains-holdings-in-danaher-corporation-dhr.html.

Shares of Danaher Corporation (NYSE DHR) opened at 87.17 on Wednesday. The stock has a market cap of $60.56 billion, a price-to-earnings ratio of 27.82 and a beta of 1.03. Danaher Corporation has a one year low of $75.71 and a one year high of $88.62. The company has a 50 day moving average price of $85.42 and a 200-day moving average price of $84.17.

Danaher Corporation (NYSE:DHR) last posted its earnings results on Thursday, July 20th. The conglomerate reported $0.99 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.97 by $0.02. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The firm had revenue of $4.51 billion during the quarter, compared to the consensus estimate of $4.50 billion. During the same quarter last year, the firm earned $0.90 EPS. The firm’s revenue for the quarter was up 6.3% on a year-over-year basis. Equities analysts predict that Danaher Corporation will post $3.96 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, September 29th will be issued a $0.14 dividend. The ex-dividend date is Thursday, September 28th. This represents a $0.56 annualized dividend and a yield of 0.64%. Danaher Corporation’s dividend payout ratio (DPR) is presently 17.83%.

About Danaher Corporation

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply